Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P0
Near historical low
vs 2Y Ago
-304.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-2319.03%
202497.27%
20237.62%
2022-23.47%
2021-45.81%
2020-36.35%
2019-27.88%
2018-43.49%
20170.00%